Cellular Immune Response to Hepatitis Viruses
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: 30 November 2026 | Viewed by 4843
Special Issue Editor
2. The Lyon Hepatology Institute, IHU EVEREST, F-69004 Lyon, France
Interests: development of new host-targeted therapeutic strategies against chronic HBV and HDV infection
Special Issue Information
Dear Colleagues,
The liver presents a delicate balance between immunological tolerance and the rapid elimination of invading pathogens. The alteration of this equilibrium can lead to hepatitis and the potential development of severe complications. In addition to the classical hepatitis A–E viruses (i.e., HAV, HBV, HCV, HDV, and HEV), a wide variety of emerging and re‑emerging agents, which include yellow fever (YFV), dengue (DENV), Zika (ZIKV), Crimean–Congo hemorrhagic fever (CCHFV), Rift Valley fever (RVFV), Lassa (LASV), and Ebola (EBOV), also target the liver and contribute to the global burden of viral hepatitis. Understanding how each of these viruses interacts, evades, and reshapes innate and adaptive immune responses is central for the design of novel prophylactic and therapeutic strategies.
This Special Issue, “Cellular Immune Response to Hepatitis Viruses”, will focus on the most recent developments related to viral sensing, immune evasion, immunopathology, immunomodulatory agents, and the use of preclinical models for the study of hepatotropic viruses.
We invite submissions of original research, short communications, and review articles on this highly dynamic field. We look forward to receiving your contributions.
Dr. Armando Andres Roca Suarez
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- viral hepatitis
- viral/host interactions
- immune response
- immune evasion
- immunopathogenesis
- immunomodulatory therapy
- pre-clinical models
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
